Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
Objective The prognostic impact of interstitial lung disease (ILD) subclassification based on both high-resolution computed tomography (HRCT) scan findings and histopathological findings is unknown. Methods We retrospectively analyzed 104 patients who were diagnosed with clinical ILD according to HR...
Gespeichert in:
Veröffentlicht in: | General thoracic and cardiovascular surgery 2023-02, Vol.71 (2), p.129-137 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
The prognostic impact of interstitial lung disease (ILD) subclassification based on both high-resolution computed tomography (HRCT) scan findings and histopathological findings is unknown.
Methods
We retrospectively analyzed 104 patients who were diagnosed with clinical ILD according to HRCT scan findings and who underwent lung cancer surgery. Via an expert multidisciplinary discussion, we re-classified HRCT scan findings and validated the histopathological patterns of ILDs in lung specimens.
Results
There were several mismatches between HRCT scan findings and histological patterns. Moreover, 87 (83.7%) and 6 (5.8%) patients were diagnosed with definitive ILD and pathological non-ILD, respectively. Finally, 82 patients with idiopathic interstitial pneumonias (IIPs) were divided into the idiopathic pulmonary fibrosis (IPF) (
n
= 61) group and the other group (
n
= 21). The 5-year overall survival rate of the IPF group was significantly lower than that of the other group (22.8% vs 67.9%;
p
= 0.011). Sub-classification of IIPs was found to be an independent prognostic factor for overall survival in patients with lung cancer.
Conclusion
An accurate diagnosis of IIPs/IPF according to both HRCT scan findings and histological patterns is important for providing an appropriate treatment among patients with lung cancer who presented with clinical ILD. |
---|---|
ISSN: | 1863-6705 1863-6713 |
DOI: | 10.1007/s11748-022-01868-6 |